ACLX PEER ANALYSIS

Arcellx Inc — metric-by-metric comparison with peers and the industry median

ACLXArcellx Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ACLXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ACLX	TLX	CSL	MSB	Ind. Median
P/E	-28.30●	—	30.04	—	18.00
P/B	16.10	6.26	2.25●	—	3.60
EV/EBITDA	-30.94●	118.24	10.37	—	15.20
P/S	290.72	3.18	2.67●	30.99	10.43

Financial Health
Metric	ACLX	TLX	CSL	MSB	Ind. Median
Current Ratio	4.44●	1.43	2.57	—	5.90
Debt/Equity	23.9%●	112.3%	67.4%	—	10.9%
NetDebt/EBITDA	1.79●	13.13	2.22	—	1.15

Profitability
Metric	ACLX	TLX	CSL	MSB	Ind. Median
Net Margin	-1,027.3%	-0.9%	9.2%●	-115.3%	-125.7%
ROE	-53.4%	-1.8%	7.7%●	-11.3%	-47.5%
ROA	-34.8%	-0.7%	3.8%●	-8.6%	-35.8%
EBITDA Margin	-888.3%	3.0%	32.8%●	-76.6%	-105.8%

Growth + Dividend
Metric	ACLX	TLX	CSL	MSB	Ind. Median
Rev. Growth	-79.4%	56.3%	4.8%	410.4%●	5.1%
NI Growth	—	—	-39.4%	—	12.1%
Div. Yield	—	—	2.5%●	0.0%	0.2%
Payout	—	—	103.1%	0.0%	0.0%

Valuation
Metric	ACLX	LGND	PTCT	SRRK	CELC	MIRM	Ind. Median
P/E	-28.30●	40.77	—	—	—	—	18.00
P/B	16.10	6.28	-40.50●	25.84	110.81	31.20	3.60
EV/EBITDA	-30.94●	26.70	—	—	—	—	15.20
P/S	290.72	22.81	8.84●	—	38,513.00	13.28	10.43

Financial Health
Metric	ACLX	LGND	PTCT	SRRK	CELC	MIRM	Ind. Median
Current Ratio	4.44	21.28●	2.44	8.64	12.31	2.09	5.90
Debt/Equity	23.9%	45.3%	-218.9%●	74.5%	365.4%	133.5%	10.9%
NetDebt/EBITDA	1.79	-1.47●	12.52	0.69	-0.29	0.08	1.15

Profitability
Metric	ACLX	LGND	PTCT	SRRK	CELC	MIRM	Ind. Median
Net Margin	-1,027.3%	55.9%●	-22.6%	—	-125,250.6%	-140.2%	-125.7%
ROE	-53.4%	17.1%●	—	-138.9%	-275.2%	-335.8%	-47.5%
ROA	-34.8%	12.6%●	-6.8%	-86.7%	-61.4%	-101.0%	-35.8%
EBITDA Margin	-888.3%	81.0%●	-14.5%	—	-112,116.2%	-133.6%	-105.8%

Growth + Dividend
Metric	ACLX	LGND	PTCT	SRRK	CELC	MIRM	Ind. Median
Rev. Growth	-79.4%	51.2%●	-53.3%	—	26.9%	50.2%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ACLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of May 15, 26. This content is for informational purposes only and is not investment advice.